Chimerix to Present at H.C. Wainwright Global Investment Conference
DURHAM, N.C., May 17, 2022 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission it…
News
ORIC Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference
SOUTH SAN FRANCISCO and SAN DIEGO, Calif., May 17, 2022 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
ERYTECH to Present at the H.C. Wainwright Global Investment Conference
ERYTECH to Present at the H.C. Wainwright Global Investment Conference Cambridge, MA (U.S.) and Lyon…
Codexis to Participate in Upcoming Healthcare Conferences
REDWOOD CITY, Calif., May 17, 2022 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading…
XOMA to Present at H.C. Wainwright Global Investment Conference
EMERYVILLE, Calif., May 17, 2022 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty…
Histogen to Present at the H.C. Wainwright Global Investment Conference
SAN DIEGO, May 17, 2022 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics…
Molecular Templates to Present at Upcoming Investor Conferences
AUSTIN, Texas, May 17, 2022 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,”…
CinCor Pharma to Present at Upcoming Investor Conferences
WALTHAM, Mass., May 17, 2022 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (NASDAQ: CINC) today announced…
Connect Biopharma Presents CBP-201 Target Engagement and Immune Modulation Data at the Society for Investigative Dermatology Annual Conference
SAN DIEGO, CA and TAICANG, China, May 17, 2022 (GLOBE NEWSWIRE) — Connect Biopharma Holdings…
Celyad Oncology to Present at the H.C. Wainwright Global Investment Conference
MONT-SAINT-GUIBERT, Belgium, May 17, 2022 (GLOBE NEWSWIRE) — Celyad Oncology SA (Euronext & Nasdaq: CYAD)…
Beyond Air® Presents Positive Study Update from the At-Home LungFit® GO Pilot Study for Nontuberculous Mycobacterial Lung Disease at the American Thoracic Society International Conference 2022
Methemoglobin (MetHb) and Nitrogen Dioxide (NO2) Levels (<10% and <5 ppm, respectively are safe)* *Graphs…
Adverum Presents Data at ASGCT Further Supporting Phase 2 Development Plans for ADVM-022
– Human equivalent ADVM-022 dose of 6E10 vg/eye provided therapeutic levels of aflibercept in NHPs…
Aquestive Therapeutics Announces CEO Transition
Daniel Barber, current Chief Operating Officer of Aquestive, appointed as President and Chief Executive Officer…
Casma Therapeutics to Present at UBS 2022 Global Healthcare Conference
CAMBRIDGE, Mass., May 17, 2022 (GLOBE NEWSWIRE) — Casma Therapeutics, Inc., a biotechnology company engaging…
Keros Therapeutics Presents Results from a Preclinical Study of RKER-012 in Pulmonary Arterial Hypertension at the American Thoracic Society International Conference
LEXINGTON, Mass., May 17, 2022 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”)…
Talaris Therapeutics to Present at the H.C. Wainwright Global Investment Conference
BOSTON and LOUISVILLE, Ky., May 17, 2022 (GLOBE NEWSWIRE) — Talaris Therapeutics, Inc. (Nasdaq: TALS),…
MacroGenics to Participate in Upcoming Investor Conference
ROCKVILLE, MD, May 17, 2022 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company…
Arvig Rolls Out WiFi 6e Compatible Technology
PERHAM, Minn., May 17, 2022 (GLOBE NEWSWIRE) — Arvig is now offering a new series…
The Bank of San Antonio, Texas A&M University-San Antonio Partner to Offer Local Entrepreneurs Hands-On Business Training Free of Charge
The STRIDE program launches in the Fall of 2022 and a female entrepreneur’s STRIDE program…
GoFundMe Completes Acquisition of Classy
Depelsha McGruder, Ford Foundation COO, appointed to GoFundMe’s Board of Directors REDWOOD CITY, Calif.–(BUSINESS WIRE)–GoFundMe,…